When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NVO - Goodbye To Gilead As ViiV Merck Besiege Its HIV Citadel
Novo Nordisk A/S
Background - why it's just another stock now
At its peak in 2014-5, Gilead Sciences (GILD) had almost everything going for it. Its HCV drugs had the sales momentum and headlines. And a growing number of analysts were signing on to the argument I put forth in The Importance Of TAF To Gilead from Oct. 4, 2014, namely that there was much more value in GILD's HIV lineup than the Street was thinking. With EPS estimates in the 2015 period around $12-13 and the stock trading in the $100-120+ range, the P/E of